Alpha Tau Medical Ltd. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD -32.05 M

Alpha Tau Medical Ltd. EBITDA is USD -32.05 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -5.36% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Alpha Tau Medical Ltd. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -33.86 M, a 31.77% change year over year.
  • Alpha Tau Medical Ltd. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -25.70 M, a 76.01% change year over year.
  • Alpha Tau Medical Ltd. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -14.60 M, a 48.38% change year over year.
  • Alpha Tau Medical Ltd. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -9.84 M, a 22.14% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)